Commission Implementing Regulation (EU) 2023/741 of 5 April 2023 concerning the non-renewal of the approval of the active substance oxamyl, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)
Article 2Amendment to Implementing Regulation (EU) No 540/2011
In force · version of Apr 11, 2023
In Part A of the Annex to Implementing Regulation (EU) No 540/2011, row 116 on oxamyl is deleted.